Showing results (71-80 of 1,736) with videos related to

Sort By:
Pageof 174
Harm Reduction Journal|July 11, 2019
Psychedelic microdosing benefits and challenges: an empirical codebookThomas Anderson, Rotem Petranker, Adam Christopher, et al.
Harm Reduction Journal|February 5, 2022
The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19Jennifer J Carroll, Sarah Mackin, Clare Schmidt, et al.
Harm Reduction Journal|April 6, 2022
"A place to be safe, feel at home and get better": including the experiential knowledge of potential users in the design of the first wet service in Montreal, CanadaRossio Motta-Ochoa, Natalia Incio-Serra, Hélène Poliquin, et al.
Harm Reduction Journal|February 26, 2022
Gambling treatment service providers' views about contingency management: a thematic analysisLucy Dorey, Darren R Christensen, Richard May, et al.
Harm Reduction Journal|March 5, 2022
Dealing with low access to harm reduction: a qualitative study of the strategies and risk environments of people who use drugs in a small Swedish cityJulie Holeksa
Harm Reduction Journal|March 5, 2022
Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York CityAlex S Bennett, Joy Scheidell, Jeanette M Bowles, et al.
Harm Reduction Journal|August 16, 2018
From client to co-worker: a case study of the transition to peer work within a multi-disciplinary hepatitis c treatment team in Toronto, CanadaPaula Tookey, Kate Mason, Jennifer Broad, et al.
Harm Reduction Journal|February 14, 2006
The war on marijuana: the transformation of the war on drugs in the 1990sRyan S King, Marc Mauer
Harm Reduction Journal|February 3, 2006
Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implicationsHan-Zhu Qian, Joseph E Schumacher, Huey T Chen, et al.
Harm Reduction Journal|February 7, 2006
Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusersStephen F Butler, Christine Benoit, Simon H Budman, et al.
Pageof 174